THERAPEUTIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS FOR… Application WO-2022195118-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022